My totally unscientific sense of things is that Jeff Bagwell is going to fall well short of the Hall of Fame in this his first year on the ballot. Peter Gammons suspects as much. And, after making the case of just how clear a Hall of Famer Bagwell is, has some pointed words for the wait-and-see-on-Bagwell crowd:
We have media members who believe in a black-and-white one-and-done code when it comes to Cooperstown. We have those who believe their eyes are enough when it comes to making judgment, bifocals or no bifocals. Two springs ago, Mike Piazza asked, “How can someone write that I was a steroid user because of acne? When did I fail any test?” Thankfully, Piazza pushes that issue, as one of the greatest offensive catchers and a surefire Hall of Fame performer. Barry Bonds, Sammy Sosa and Roger Clemens are going to be fascinating votes in future years, all very different case studies that will dictate prolonged, complex debates.
Meanwhile, Bagwell never failed any test, to our knowledge. Did he lose body mass later in his career? Yes; so did the indefatigable gym rat Carlton Fisk after he stopped lifting for hours every day.
I have seen no one make a purely merit-based case against Bagwell. It’s all either vague “let’s wait and see” stuff or vague references to the inflated offensive numbers of the 1990s. A few have specifically mentioned PEDs, but only a few. In reality, I think that just about everyone not voting for Bagwell is doing so because they think he did steroids.
And I suppose I see why a big power hitter of the 90s is under suspicion, but where does it all end? If you suspect Bagwell, why don’t you suspect Frank Thomas? Because he said he didn’t do steroids? Hell, so did Palmeiro. Do you suspect Piazza? Biggio? Randy Johnson? All of them did quite amazing things too. Given that big players, small players, fast players, slow players, pitchers, hitters, stars and scrubs have all been connected to PEDs, why isn’t everyone a suspect? And if they are, why isn’t everyone getting the Jeff Bagwell treatment?
The level of subjectivity being applied in this arena is doing more harm to the Hall of Fame than letting in one person who was later found to have done steroids would ever do.
OXON HILL, Md — There used to be a time when postseason money was bigger than most players’ actual salaries. Winning a pennant in baseball’s Golden Age was great for its own sake, but if you were one of the guys who hung around with, say, the Yankees for a long time like Frank Crosetti, the money was basically life-changing.
That’s not the case any longer, but the money is still pretty good, as evidenced by the postseason shares handed out for this past postseason, which were just announced and are set forth below.
Shares come from the “players’ pool,” which calculated by taking 50 percent of the gate receipts from the Wild Card Games; 60 percent of the gate receipts from the first three games of the Division Series; 60 percent of the gate receipts from the first four games of the League Championship Series; and 60 percent of the gate receipts from the first four games of the World Series. The players’ pool is divided among the 10 Postseason Clubs. The 2016 players’ pool was a record total of $76,627,827.09. Last year it was $69,882,149.26.
The clubs themselves decide how many shares to allocate, with the players making decisions regarding which part timers, cup-of-coffee callups, staffers, etc. get. They also have the ability to hand out straight cash awards in whatever amount they want as opposed to a percentage cut of the postseason money.
- Chicago Cubs (Share of Players’ Pool: $27,586,017.75; value of each of full share: $368,871.59) – The Cubs issued 66 full shares, a total of 8.7 partial shares and four cash awards;
- Cleveland Indians (Share of Players’ Pool: $18,390,678.50; value of each of full share: $261,804.65) – The Indians issued 60 full shares, a total of 8.75 partial shares and 16 cash awards.
- Los Angeles Dodgers (Share of Players’ Pool: $9,195,339.25; value of each of full share: $123,741.24) – The Dodgers issued 65 full shares, a total of 8.285 partial shares and 20 cash awards.
- Toronto Blue Jays (Share of Players’ Pool: $9,195,339.25; value of each of full share: $123,045.09) – The Blue Jays issued 66 full shares, a total of 7.75 partial shares and 15 cash awards.
- Boston Red Sox (Share of Players’ Pool: $2,490,404.38; value of each of full share: $33,761.22) – The Red Sox issued 61 full shares, a total of 10.686 partial shares and 14 cash awards.
- San Francisco Giants (Share of Players’ Pool: $2,490,404.38; value of each of full share: $36,443.03) – The Giants issued 57 full shares, a total of 10.5 partial shares and nine cash awards.
- Texas Rangers (Share of Players’ Pool: $2,490,404.38; value of each of full share: $38,422.69) – The Rangers issued 54 full shares, a total of 10.19 partial shares and seven cash awards.
- Washington Nationals (Share of Players’ Pool: $2,490,404.38; value of each of full share: $35,442.68) – The Nationals issued 60 full shares, a total of 10.209 partial shares and one cash award.
- Baltimore Orioles (Share of Players’ Pool: $1,149,417.41; value of each of full share: $18,351.02) – The Orioles issued 52 full shares, a total of 8.36 partial shares and 30 cash awards.
- New York Mets (Share of Players’ Pool: $1,149,417.41; value of each of full share: $17,951.65) – The Mets issued 51 full shares, a total of 12.75 partial shares and five cash awards.
It was rumored to be close last night but now Bob Nightengale of USA Today is reporting that the Cubs and Royals have agreed to the Wade Davis for Jorge Soler deal. Jeff Passan of Yahoo first reported that the deal was close last night. It’s not a completely done deal as the official announcement is pending physicals, but an announcement could come this morning. Ken Rosenthal reports that, assuming it gets done, it will be a straight-up deal, with no other players involved.
Davis has been one of the most dominant relievers in baseball over the past three seasons, posting a 1.18 ERA with 47 saves and a 234/59 K/BB ratio in 182.2 innings. He did, however, miss a lot of time in 2016 — basically the month of August — due to arm trouble and expecting him to be the circa 2014 Wade Davis is probably unrealistic. He’s owed $10 million for 2017 and can become a free agent after the 2017 season. He’ll fill the void left by the departing Aroldis Chapman as Joe Maddon and the World Series champs’ closer.
Soler, who will be 25 when the 2017 season begins, hit .238/.333/.436 with 12 homers and 36 RBI in 86 games last season. He strikes out a lot but takes walks t00 and has shown some good power in short bursts. He’s the sort of player who one could easilsy see putting things together to become a solid regular, which makes him a decent return for giving up a closer in his walk year.